학술논문

Carfilzomib, lenalidomide and dexamethasone (KRd) versus elotuzumab-KRd as induction and consolidation in transplant-eligible patients with newly diagnosed multiple myeloma: post-induction IMWG and MRD response of a randomized multicenter study
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; OCT 3 2023, 46 p58-p59, 2p. Supplement: 5
Subject
Language
English
ISSN
22965262